Rocket Pharmaceuticals received FDA accelerated approval for Kresladi, validating its gene therapy platform. Find out why RCKT stock is a hold.
Currency fragmentation, commodity risk and geopolitical tension are now a connected risk vector. They don’t move sequentially ...
Why nuclear makes sense for the Red Planet. Google’s new memory math for AI. Why video games help you sleep. All that and ...
All you had to do was pay attention to the polar coordinates lecture in [trigonometry], and you could have discovered a 6x ...
Cloudflare’s Dynamic Workers aim to simplify how enterprises execute AI-generated code, signaling a shift toward lightweight, ...
Microsoft Defender stopped a human-operated ransomware attack that abused Group Policy Objects (GPOs) to disable defenses and ...
Medium-dose OCU410 met the 12-month primary endpoint, reducing GA lesion growth by 31% versus control (P < .05), with ...
Discusses FDA Approval of KRESLADI Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1 March 27, 2026 8:30 ...
Judge Susan C. Rodriguez of the Western District of North Carolina heard arguments from all parties involved in the Joe Gibbs ...
Overview: Poor data validation, leakage, and weak preprocessing pipelines cause most XGBoost and LightGBM model failures in production.Default hyperparameters, ...
Google's TurboQuant reduces the KV cache of large language models to 3 bits. Accuracy is said to remain, speed to multiply.
BIO-Europe Spring 2026 brought together more than 3,700 innovators in the life sciences industry all under the same roof.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results